Allogene Therapeutics (ALLO) Shares Issued (2018 - 2026)

Allogene Therapeutics has disclosed Shares Issued across 9 years of filings, most recently posting $4000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $4000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $899000.0 (up 2190.7% YoY), and the FY2025 annual result was $895000.0, up 10.09% from the prior year.
• Shares Issued came in at $4000.0 for Q1 2026 at Allogene Therapeutics, down from $895000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $1.6 million in Q2 2023 to a low of -$1.1 million in Q3 2022.
• The 5-year median for Shares Issued is $326000.0 (2023), against an average of $382545.5.
• Across the five-year window, Shares Issued soared 227.31% in 2023 and tumbled 102.68% in 2024, its largest moves.
• Allogene Therapeutics' Shares Issued stood at -$443000.0 in 2022, then jumped by 227.31% to $564000.0 in 2023, then tumbled by 107.62% to -$43000.0 in 2024, then surged by 2181.4% to $895000.0 in 2025, then sank by 99.55% to $4000.0 in 2026.
• The last three Shares Issued figures came in at $4000.0 (Q1 2026), $895000.0 (Q4 2025), and -$43000.0 (Q2 2024), per Business Quant data.